Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 13,254,775	$ 14,764,346
Accounts receivable, net	1,063,613	943,272
Accounts receivable, related party net	269,973	0
Prepaid expenses and other current assets	622,080	375,360
Inventories, net	1,799,908	1,541,513
Advances on contracts	1,217,253	1,309,260
Total current assets	18,227,602	18,933,751
Furniture, fixtures and equipment, net	20,325	23,713
Intangibles, net	264,192	277,619
Right of use assets	528,907	550,511
Other assets	24,150	24,150
Total assets	19,065,176	19,809,744
Current liabilities:
Accounts payable	1,012,093	780,428
Accounts payable, related party	1,128,919	395,857
Accrued expenses and other payables	1,335,451	1,417,248
Accrued expenses, related party	257,815	414,241
Current portion of finance lease liabilities	8,743	8,545
Current portion of operating lease liabilities	83,585	81,001
Total current liabilities	3,826,606	3,097,320
Non-current portion of finance lease liabilities	17,801	20,062
Non-current portion of operating lease liabilities	454,857	476,980
Total liabilities	4,299,264	3,594,362
Commitments
Stockholders’ equity
Common stock, par value $.001;authorized 100,000,000 shares; 68,153,336 shares issued at March 31, 2022 and December 31, 2021 and 68,120,003 shares outstanding as March 31, 2022 and December 31, 2021;	68,153	68,153
Additional paid in capital	125,385,315	124,915,560
Accumulated deficit	(109,605,997)	(107,704,274)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	14,935,955	16,367,923
Noncontrolling interest	(170,043)	(152,541)
Total stockholders’ equity	14,765,912	16,215,382
Total liabilities and stockholders’ equity	$ 19,065,176	$ 19,809,744